Medvi: Different approaches to weight loss As GLP-1 medications become more widely available, more online programs are offering ways to access them
We use GLP-1 in Cincinnati to treat: Excess fat in the stomach, thighs, buttocks, arms, and more High blood sugar Poor cardiac health Obesity A weight loss study followed up with 102 patients who were taking a GLP-1 medication after 6 months and found that: 89 (87.3%) achieved weight loss of 5% or more 56 (54.9%) achieved weight loss of 10% or more 24 (23.5%) achieved weight loss of 15% or more 8 (7.8%) achieved weight loss of 20% or more GLP-1 agonists are clearly effective for weight loss, transforming the bodies of many patients
BPC-157 is a 15-amino-acid pentadecapeptide most often studied in tendon, gut, and vessel models
Scientific References Ozempic 0.5 mg solution for injection in pre-filled pen
50% of patients achieved more than 10% weight loss compared to 0% on lifestyle changes alone 23.1% of patients achieved more than 15% weight loss compared to 0% on lifestyle changes alone
Host-gut microbiota metabolic interactions